Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.03B |
| 2 |
Broadcom
AVGO
|
$1.01B |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$892M |
| 4 |
Amazon
AMZN
|
$876M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$765M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$459M |
| 2 |
Yum China
YUMC
|
$421M |
| 3 |
Merck
MRK
|
$362M |
| 4 |
ASML
ASML
|
$313M |
| 5 |
Microchip Technology
MCHP
|
$298M |
Sector Composition
| 1 | Technology | 24.74% |
| 2 | Financials | 12.44% |
| 3 | Industrials | 11.72% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Savara
SVRA
$643M
| $199K | ﹤0.01% |
46,958
+3,850
| +9% | +$16.3K |
|
3402
LivePerson
LPSN
$89.9M
| $197K | ﹤0.01% |
153,819
+675
| +0.4% | +$864 |
|
3403
iShares MSCI Hong Kong ETF
EWH
$712M
| $197K | ﹤0.01% |
+10,542
| New | +$197K |
|
|
AIOT
3404
PowerFleet, Inc. Common Stock
AIOT
$670M
| $196K | ﹤0.01% |
39,294
-1,663
| -4% | -$8.32K |
|
3405
Sana Biotechnology
SANA
$752M
| $196K | ﹤0.01% |
47,180
+896
| +2% | +$3.73K |
|
3406
Beyond Meat
BYND
$189M
| $196K | ﹤0.01% |
28,847
+327
| +1% | +$2.22K |
|
3407
Altimmune
ALT
$334M
| $195K | ﹤0.01% |
31,711
+968
| +3% | +$5.94K |
|
3408
Innodata
INOD
$1.38B
| $194K | ﹤0.01% |
11,549
-403,417
| -97% | -$6.77M |
|
3409
Xeris Biopharma Holdings
XERS
$1.27B
| $193K | ﹤0.01% |
67,666
+1,137
| +2% | +$3.24K |
|
3410
Y-mAbs Therapeutics
YMAB
$390M
| $191K | ﹤0.01% |
14,556
+329
| +2% | +$4.33K |
|
3411
Aehr Test Systems
AEHR
$765M
| $191K | ﹤0.01% |
14,835
-17,288
| -54% | -$222K |
|
3412
Zentalis Pharmaceuticals
ZNTL
$126M
| $189K | ﹤0.01% |
51,462
-2,347
| -4% | -$8.64K |
|
3413
Getty Images
GETY
$772M
| $187K | ﹤0.01% |
48,963
+549
| +1% | +$2.09K |
|
3414
Capricor Therapeutics
CAPR
$308M
| $185K | ﹤0.01% |
12,178
+44
| +0.4% | +$669 |
|
3415
Neumora Therapeutics
NMRA
$272M
| $184K | ﹤0.01% |
13,907
+462
| +3% | +$6.1K |
|
3416
Microvast
MVST
$829M
| $183K | ﹤0.01% |
735,445
+51,603
| +8% | +$12.9K |
|
3417
Pulse Biosciences
PLSE
$1.02B
| $183K | ﹤0.01% |
10,429
-382
| -4% | -$6.7K |
|
|
FUND
3418
Sprott Focus Trust
FUND
$247M
| $183K | ﹤0.01% |
23,721
-26,396
| -53% | -$203K |
|
3419
Evolv Technologies
EVLV
$1.39B
| $181K | ﹤0.01% |
44,734
+715
| +2% | +$2.9K |
|
3420
Olema Pharmaceuticals
OLMA
$570M
| $181K | ﹤0.01% |
15,155
-327
| -2% | -$3.9K |
|
|
DADA
3421
DELISTED
Dada Nexus
DADA
| $180K | ﹤0.01% |
94,865
-525,824
| -85% | -$999K |
|
3422
Scholar Rock
SRRK
$3.02B
| $180K | ﹤0.01% |
22,413
+403
| +2% | +$3.23K |
|
3423
MaxCyte
MXCT
$150M
| $176K | ﹤0.01% |
45,248
-222
| -0.5% | -$864 |
|
3424
Noodles & Co
NDLS
$31.1M
| $175K | ﹤0.01% |
146,160
+648
| +0.4% | +$778 |
|
3425
Alector
ALEC
$305M
| $175K | ﹤0.01% |
37,580
+1,092
| +3% | +$5.09K |
|